Author

Frank Waldron-Lynch

Vertex Pharmaceuticals (United States)ORCID 0000-0002-0597-4328Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Dominik Trzupek· 1 shared Fiona HameyiD· 1 shared Jane KennetiD· 1 shared Jennie H. M. YangiD· 1 shared Jiayuan ZhangiD· 1 shared John A. ToddiD· 1 shared Leila GodfreyiD· 1 shared Linda S. WickeriD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Dominik Trzupek

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Low-dose IL-2 reduces IL-21+ T cells and induces a long-lived anti-inflammatory gene expression signature inversely modulated in COVID-19 patients

Jiayuan Zhang, Fiona Hamey, Dominik Trzupek, Marius Mickunas, Mercede Lee, Leila Godfrey, Jennie H. M. Yang, Marcin Ł. Pękalski, Jane Kennet, Frank Waldron-Lynch, Mark L. Evans, Timothy I. M. Tree, Linda S. Wicker, John A. Todd, Ricardo C. Ferreira

medRxiv · Apr 5, 2022 · PreprintGenetic & Genomic Medicine